Yang DJ, Kim CG, Schechter NR, et al. Imaging with 99Tcm-EC-DG targeted at the multifunctional glucose transport system: feasibility study with rodents[J]. Radiology, 2003, 226: 465-473.
[2]
Yang D, Yukihiro M, Yu DF, et al. Assessment of therapeutic tumor response using 99Tcm-ethylenedicysteine-glucosamine[J]. Cancer Biother Radiopharm, 2004, 19(4): 443-456.
[3]
Liang J, Chen Y, Huang Z, et al. Early chemotherapy response evaluation in tumors by 99Tcm-DTPA-DG[J]. Cancer Biother Radiopharm, 2008, 23(3): 363-370.
Chen Y, Huang ZW, He L, et al. Synthesis and evaluation of a technetium-99m-labeled diethylenetriaminepentaacetate-deoxyglucose complex ([99Tcm]-DTPA-DG) as a potential imaging modality for tumors[J]. Appl Radiat Isot, 2006, 64(3): 342-347.
[9]
Welling MM, Alberto R. Performance of a 99Tcm-labelled 1-thio-beta-D-glucose 2,3,4,6-tetra-acetate analogue in the detection of infections and tumours in mice: a comparison with [18F]FDG[J]. Nucl Med Commun, 2010, 31(3): 239-248.
[10]
Bayly SR, Fisher CL, Storr T, et al. Carbohydrate conjugates for molecular imaging and radiotherapy: 99Tcm(Ⅰ) and 186Re(Ⅰ) tricarbonyl complexes of N-（2’-hydroxybenzyl）-2-amino-2-deoxy-D-glucose[J]. Bioconjug Chem, 2004, 15: 923-926.
[11]
Chen XJ, Li L, Liu F, et al. Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor [J]. Bioorg Med Chem Lett, 2006, 16(21): 5 503-5 506.
[12]
Zhang JB, Ren JL, Lin X, et al. Synthesis and biological evaluation of a novel 99mTc nitride radiopharmaceutical with deoxyglucose dithiocarbamate, showing tumor uptake [J]. Bioorg Med Chem Lett, 2009, 19(10): 2 752-2 754.
Schibli R, Dumas C, Petrig J, et al. Synthesis and in vitro characterization of organometallic rhenium and technetium glucose complexes against Glut 1 and hexokinase[J]. Bioconjug Chem, 2005, 16(1): 105-112.
